Shan Fu - Sinovac Biotech Independent Director

Mr. Shan FU serves as Independent Director of the company, Mr. Fu was Senior Managing Director in the Private Equity group and the Chief Representative of Blackstones Beijing Office. Additionally, Mr. Fus qualifications include experience in the Department of Foreign Investment in Chinas National Development and Reform Commission, the State Economic and Trade Commission, the Office of Economic and Trade in State Council, and the Office of Production in State Council.
Age: 44        

Management Efficiency

The company has Return on Asset of 6.42 % which means that on every $100 spent on asset it made $6.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.53 % implying that it generated $11.53 on every 100 dollars invested.
The company has 20.98M in debt with debt to equity (D/E) ratio of 6.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Sinovac Biotech has Current Ratio of 4.91 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Entity Summary

Sinovac Biotech Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the Peoples Republic of China. Sinovac Biotech Ltd. was founded in 1999 and is based in Beijing, the Peoples Republic of China. Sinovac Biotech operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 735 people.Sinovac Biotech Ltd (SVA) is traded on BATS Exchange in USA and employs 735 people.

Sinovac Biotech Leadership Team

Weidong Yin, Chairman, CEO and President Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Meng Mei, Independent Director
Pengfei Li, Director
Simon Anderson, Independent Director
Shan Fu, Independent Director
Stephanie Carrington, IR Contact Officer
Guowei Wang, Director
Nan Wang, CFO and VP of Bus. Devel.
Fung Hoi, Director
Jing Li, Vice President Quality and Production
Helen Yang, IR Contact Officer
Yuk Lo, Independent Director
Jue Lee, Independent Director
Xiaomei Yin, Vice President Sales and Marketing
Jianzeng Cao, Director
Qiang Gao, Vice President Research and Development
Ming Xia, VP of Sales and Marketing

Stock Performance Indicators

Did you try this?

Run Positions Ratings Now


Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Currently Active Assets on Macroaxis

Purchased few shares of
few hours ago
Traded for 188.14
Purchased a lot of shares of
few hours ago
Traded for 150.35
Purchased few shares of
few hours ago
Traded for 175.29
Purchased a lot of shares of
few hours ago
Traded for 152.77
Purchased over 300 shares of
few hours ago
Traded for 9.25
Also please take a look at World Market Map. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.